In cancer, INMT exhibits dual roles, either promoting drug resistance (as in prostate cancer) [19] or acting as a tumor suppressor (as in hepatocellular carcinoma and NSCLC) [89], suggesting a context-specific effect tied to its methylation capacity. This evidence concerns the gene INMT and prostate cancer.